PCPC3 comments on recent data on active surveillance from Johns Hopkins


According to a message sent out earlier today by PCPC3 — the patient-centered prostate cancer collaborative coalition — the members of the coalition are “pleased to see the recently published report by Tosoian et al. indicating a 99.9% prostate cancer-specific survival rate at 10 and 15 years post-diagnosis”.

To see the complete statement from PCPC3, please click here. A key goal of PCPC3 is for prostate cancer educational and advocacy organizations to work closely together in sending clear messages about important new information for the prostate cancer patient community.

For earlier commentary on the original paper by Tosoian et al., please see this commentary on The “New” Prostate Cancer InfoLink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: